Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Nicolas M Van Mieghem Added: 4 weeks ago
NVM Cardiology Conference Reflections: What’s Hot at TCT 2025?Join Prof Nicolas Van Mieghem, Transcatheter Interventions Online Course Director, as he shares his critical perspective on some of the key late-breaking data highlights from TCT 2025.What should we expect from the new data? Where should we take a closer look at the existing evidence and the premise of these trials? And which results… View more
Author(s): Subodh Verma Added: 2 months ago
ESC Congress 2025 - The SEMA-VR CardioLink-15 trial revealed that semaglutide may enhance endogenous progenitor cell-mediated vasculogenic repair processes.Dr Subodh Verma (University of Toronto, Toronto, CA) joins us to discuss the findings from the SEMA-VR CardioLink-15 trial. The study compared usual care with semaglutide, GLP-1RA for six months in 46 patients with either type 2 diabetes… View more
Author(s): Michael J Mack Added: 4 weeks ago
Stay Updated with Our TCT 2025 Video CoverageWe’re bringing you independent, critical insights straight from TCT 2025.Join Prof Nicolas Van Mieghem in Cardiology Conference Perspectives as he discusses what the late-breaking data could mean for your practice.Don’t miss our short Expert Interviews with investigators, offering concise analyses and practical take-home messages.Hear Dr Mirvat Alasnag… View more
Research Area(s) / Expertise:

Atrial Fibrillation

Job title: Associate Professor of Medicine; Laureate Chair in Molecular Medicine; Vice Chief, Cardiovascular Section
Dr Stavrakis is a clinical cardiac electrophysiologist and Associate Professor of Medicine at the University of Oklahoma Health Sciences Center. He is also the Director of Cardiovascular Research at the University of Oklahoma. Dr Stavrakis’ research has focused on autonomic modulation for the treatment of arrhythmias and other cardiovascular diseases, in both animal models and humans. The… View more
Added: 2 weeks ago
In this episode of Redcliffe Cardiology NVM Reflections, Professor Nicolas Van Mieghem delivers a sharp, practice-focused wrap-up of TCT 2025 from San Francisco. From the SELUTION trials redefining the role of drug-coated balloons, with nearly 80% of patients avoiding a stent, to cost-conscious calcium modification strategies in SHORTCUT and VICTORY, he distills complex data into actionable… View more
Research Area(s) / Expertise:

Cardio-oncology

Heart Failure

Job title: Assistant Professor
Dr Giselle Melendez is anAssistant Professor atWake Forest University School of Medicine, Winston-Salem, US.Commencing her scientific career at the University of South Carolina School of Medicine, Dr. Melendez focused on molecular mediators of myocardial extracellular matrix remodeling and heart failure. Notably, her research uncovered vital insights into inflammatory cytokines TNF-α, IL-6, and… View more